Culture Biosciences Patents

Patent portfolio assigned to Culture Biosciences (verified via public assignee records). Estimated patent count: 2. Cloud bioreactor / bioprocess development. Cytiva is exclusive global distributor partner (Stratyx 250); 908 Devices and Xcell Biosciences are named technology partners. Patents assigned to Culture Biosciences, Inc. (WO2020167676A1 / US20220002652A1 'Bioreactor vessel for automated fermentation system'). Serves 100+ customers but most are unnamed publicly.